Viking Therapeutics, Inc. (VKTX)
31.59
-0.69
(-2.14%)
USD |
NASDAQ |
May 07, 16:00
31.45
-0.14
(-0.44%)
After-Hours: 20:00
Viking Therapeutics Research and Development Expense (Annual) : 344.96M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Amgen, Inc. | 6.974B |
| Hims & Hers Health, Inc. | 149.30M |
| Structure Therapeutics, Inc. | 225.85M |
| Pfizer Inc. | 10.25B |